{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:05Z","timestamp":1791910565981,"version":"4.3.4"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82500543"],"award-info":[{"award-number":["82500543"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["82500505"],"award-info":[{"award-number":["82500505"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91939302"],"award-info":[{"award-number":["91939302"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["T12-101\/23-N"],"award-info":[{"award-number":["T12-101\/23-N"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["11103222"],"award-info":[{"award-number":["11103222"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["14109720"],"award-info":[{"award-number":["14109720"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","award":["SRFS2021-4S04"],"award-info":[{"award-number":["SRFS2021-4S04"]}],"id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","award":["2025-N-09-13"],"award-info":[{"award-number":["2025-N-09-13"]}],"id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Hong Kong Health Bureau","doi-asserted-by":"publisher","award":["07181286"],"award-info":[{"award-number":["07181286"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.pharmthera.2026.109053","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:39:27Z","timestamp":1780673967000},"page":"109053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Colchicine in cardiovascular medicine: Current perspectives on mechanisms and clinical therapeutics"],"prefix":"10.1016","volume":"285","author":[{"given":"Huanyu","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chak Kwong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minchun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.pharmthera.2026.109053_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.043791","article-title":"Preoperative colchicine and conduction disturbances after Transcatheter aortic valve implantation: A US retrospective cohort analysis","volume":"14","author":"Abdelsayed","year":"2025","journal-title":"Journal of the American Heart Association"},{"issue":"42","key":"10.1016\/j.pharmthera.2026.109053_bb0010","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","volume":"36","author":"Adler, Y., Charron, P., Imazio, M., Badano, L., Bar\u00f3n-Esquivias, G., Bogaert, J., Brucato, A., Gueret, P., Klingel, K., Lionis, C., Maisch, B., Mayosi, B., Pavie, A., Ristic, A. D., Sabat\u00e9 Tenas, M., Seferovic, P., Swedberg, K., Tomkowski, W., & ESC Scientific Document Group","year":"2015","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109053_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad169","article-title":"Safety and efficacy of colchicine for the prevention of post-operative atrial fibrillation in patients undergoing cardiac surgery: A meta-analysis of randomized controlled trials","volume":"25","author":"Agarwal","year":"2023","journal-title":"EP Europace"},{"issue":"7 Pt 2","key":"10.1016\/j.pharmthera.2026.109053_bb0020","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jacep.2023.02.003","article-title":"Prophylactic colchicine after radiofrequency ablation of atrial fibrillation: The PAPERS study","volume":"9","author":"Ahmed","year":"2023","journal-title":"JACC Clinical Electrophysiology"},{"issue":"6\u20137","key":"10.1016\/j.pharmthera.2026.109053_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.acvd.2016.10.004","article-title":"COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response","volume":"110","author":"Akodad","year":"2017","journal-title":"Archives of Cardiovascular Diseases"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109053_bb0030","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.31309","article-title":"Drug-drug interactions and the clinical tolerability of colchicine among patients with COVID-19: A secondary analysis of the COLCORONA randomized clinical Trial","volume":"7","author":"Alfehaid","year":"2024","journal-title":"JAMA Network Open"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0035","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2174\/1381612824666180123110042","article-title":"Colchicine pharmacokinetics and mechanism of action","volume":"24","author":"Angelidis","year":"2018","journal-title":"Current Pharmaceutical Design"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109053_bb0040","doi-asserted-by":"crossref","first-page":"R845","DOI":"10.1016\/j.cub.2010.08.058","article-title":"Intracellular transport: ER and mitochondria meet and greet along designated tracks","volume":"20","author":"Barlan","year":"2010","journal-title":"Current Biology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0045","article-title":"Colchicine to prevent atrial fibrillation recurrence after catheter ablation: A randomized. Placebo-Controlled Trial","volume":"17","author":"Benz","year":"2024","journal-title":"Circulation: Arrhythmia and Electrophysiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109053_bb0050","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/ATVBAHA.124.319851","article-title":"Colchicine\u2019s role in cardiovascular disease management","volume":"44","author":"Buckley","year":"2024","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0055","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.7150\/ijbs.93544","article-title":"Colchicine blocks abdominal aortic aneurysm development by maintaining vascular smooth muscle cell homeostasis","volume":"20","author":"Chen","year":"2024","journal-title":"International Journal of Biological Sciences"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114732","article-title":"Colchicine inhibits myocardial pyroptosis and reduces myocardial cell injury after myocardial infarction through the ESR1-PI3K-Akt-NF-\u03baB signaling pathway","volume":"156","author":"Chen","year":"2025","journal-title":"International Immunopharmacology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0065","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/bjp.2008.20","article-title":"Colchicine suppresses neutrophil superoxide production in a murine model of gouty arthritis: A rationale for use of low-dose colchicine","volume":"153","author":"Chia","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2020.106822","article-title":"Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells","volume":"137","author":"Cimmino","year":"2021","journal-title":"Vascular Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109053_bb0075","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.3390\/ijms24032483","article-title":"Colchicine in Athero-thrombosis: Molecular mechanisms and clinical evidence","volume":"24","author":"Cimmino","year":"2023","journal-title":"International Journal of Molecular Sciences"},{"issue":"10413","key":"10.1016\/j.pharmthera.2026.109053_bb0080","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(23)01689-6","article-title":"Effect of colchicine on perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery (COP-AF): An international randomised trial","volume":"402","author":"Conen","year":"2023","journal-title":"Lancet (London, England)"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109053_bb0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erc.13.43","article-title":"Newly available and recent advances in drug-eluting stents","volume":"11","author":"Costopoulos","year":"2013","journal-title":"Expert Review of Cardiovascular Therapy"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109053_bb0090","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109053_bb0095","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00392-021-01828-9","article-title":"Colchicine in ischemic heart disease: The good, the bad and the ugly","volume":"110","author":"D\u2019Amario","year":"2021","journal-title":"Clinical Research in Cardiology"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109053_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S1074-7613(04)00106-2","article-title":"Activation-induced polarized recycling targets T cell antigen receptors to the immunological synapse; involvement of SNARE complexes","volume":"20","author":"Das","year":"2004","journal-title":"Immunity"},{"issue":"15","key":"10.1016\/j.pharmthera.2026.109053_bb0110","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: A pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.hrthm.2014.02.002","article-title":"Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: Mid-term efficacy and effect on quality of life","volume":"11","author":"Deftereos","year":"2014","journal-title":"Heart Rhythm"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109053_bb0120","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2012.07.031","article-title":"Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: A randomized controlled study","volume":"60","author":"Deftereos","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109053_bb0125","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.121.056171","article-title":"Colchicine in cardiovascular disease: In-depth review","volume":"145","author":"Deftereos","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0135","doi-asserted-by":"crossref","first-page":"1081881","DOI":"10.3389\/fphys.2022.1081881","article-title":"Vascular smooth muscle cells in intimal hyperplasia, an update","volume":"13","author":"D\u00e9glise","year":"2022","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ahj.2022.06.002","article-title":"Select drug-drug interactions with colchicine and cardiovascular medications: A review","volume":"252","author":"Dixon","year":"2022","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109053_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10435","article-title":"Meta-analysis reveals inhibition of the inflammatory cytokine IL-6 affords limited protection post-myocardial ischemia\/infarction","volume":"8","author":"Duddu","year":"2022","journal-title":"Heliyon"},{"issue":"7293","key":"10.1016\/j.pharmthera.2026.109053_bb0150","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.119239","article-title":"Experimental evidence on colchicine\u2019s mode of action in human carotid artery plaques","volume":"406","author":"von Ehr","year":"2025","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109053_bb0160","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0006-2952(97)00093-2","article-title":"Role of P-glycoprotein in colchicine and vinblastine cellular kinetics in an immortalized rat brain microvessel endothelial cell line","volume":"53","author":"El Hafny","year":"1997","journal-title":"Biochemical Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109053_bb0165","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/j.1552-4604.1996.tb04753.x","article-title":"Oral absorption characteristics and pharmacokinetics of colchicine in healthy volunteers after single and multiple doses","volume":"36","author":"Ferron","year":"1996","journal-title":"Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1016\/j.pharmthera.2026.109053_bb0170","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00059-002-2376-5","article-title":"Colchicine for the prevention of postpericardiotomy syndrome","volume":"27","author":"Finkelstein","year":"2002","journal-title":"Herz"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/acr.24180","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Care & Research"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","article-title":"Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities","volume":"65","author":"Frangogiannis","year":"2019","journal-title":"Molecular Aspects of Medicine"},{"issue":"6054","key":"10.1016\/j.pharmthera.2026.109053_bb0185","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1207385","article-title":"ER tubules mark sites of mitochondrial division","volume":"334","author":"Friedman","year":"2011","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109053_bb0190","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3390\/pharmaceutics14071395","article-title":"The role of colchicine in atherosclerosis: From bench to bedside","volume":"14","author":"Gonz\u00e1lez","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0195","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/0735-1097(95)00345-2","article-title":"Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: Effects on restenosis and implications for catheter-based drug delivery","volume":"26","author":"Gradus-Pizlo","year":"1995","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41569-024-01110-1","article-title":"Phenotyping atherosclerotic plaque and perivascular adipose tissue: Signalling pathways and clinical biomarkers in atherosclerosis","volume":"22","author":"Grodecki","year":"2025","journal-title":"Nature Reviews. Cardiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109053_bb0205","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","article-title":"Vascular smooth muscle cells in atherosclerosis: Time for a re-assessment","volume":"117","author":"Grootaert","year":"2021","journal-title":"Cardiovascular Research"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109053_bb0210","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40264-022-01265-1","article-title":"Colchicine drug interaction errors and misunderstandings: Recommendations for improved evidence-based management","volume":"46","author":"Hansten","year":"2023","journal-title":"Drug Safety"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109053_bb0215","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0163-7258(91)90067-V","article-title":"Interactions of colchicine with tubulin","volume":"51","author":"Hastie","year":"1991","journal-title":"Pharmacology & Therapeutics"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0220","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/FJC.0000000000001317","article-title":"Preprocedural colchicine in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: A randomized controlled Trial (PodCAST-PCI)","volume":"80","author":"Hosseini","year":"2022","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"9936","key":"10.1016\/j.pharmthera.2026.109053_bb0225","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): A multicentre, double-blind, placebo-controlled, randomised trial","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109053_bb0230","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis: Results of the COlchicine for acute PEricarditis (COPE) trial","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109053_bb0235","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: Results of the CORE (COlchicine for REcurrent pericarditis) trial","volume":"165","author":"Imazio","year":"2005","journal-title":"Archives of Internal Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109053_bb0240","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): A randomized trial","volume":"155","author":"Imazio","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109053_bb0245","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis","volume":"369","author":"Imazio","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109053_bb0250","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.2014.11026","article-title":"Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: The COPPS-2 randomized clinical trial","volume":"312","author":"Imazio","year":"2014","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109053_bb0255","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1161\/CIRCULATIONAHA.111.026153","article-title":"Colchicine reduces postoperative atrial fibrillation: Results of the colchicine for the prevention of the Postpericardiotomy syndrome (COPPS) atrial fibrillation substudy","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"issue":"28","key":"10.1016\/j.pharmthera.2026.109053_bb0260","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"European Heart Journal"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0270","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/jce.15941","article-title":"Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high-power short-duration ablation","volume":"34","author":"Iqbal","year":"2023","journal-title":"Journal of Cardiovascular Electrophysiology"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0275","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pcad.2025.08.010","article-title":"Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors along with colchicine versus colchicine alone among coronary artery disease and type 2 diabetes patients","volume":"92","author":"Jaiswal","year":"2025","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0280","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/ATVBAHA.124.322252","article-title":"Colchicine inhibits smooth muscle cell phenotypic switch and aortic dissection in mice-brief report","volume":"45","author":"Jiang","year":"2025","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109053_bb0265","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1093\/eurheartj\/ehq319","article-title":"COlchicine for the prevention of the post-pericardiotomy syndrome (COPPS): A multicentre, randomized, double-blind, placebo-controlled trial","volume":"31","author":"Imazio","year":"2010","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109053_bb0285","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0290","first-page":"11","article-title":"Role of colchicine in reducing reperfusion injury in STEMI patients who undergo primary percutaneous coronary intervention: A randomized clinical Trial","volume":"57","author":"Karim","year":"2025","journal-title":"Acta Medica Indonesiana"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109053_bb0295","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine--Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12872-023-03697-8","article-title":"Colchicine ameliorates myocardial injury induced by coronary microembolization through suppressing pyroptosis via the AMPK\/SIRT1\/NLRP3 signaling pathway","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cardiovascular Disorders"},{"issue":"17","key":"10.1016\/j.pharmthera.2026.109053_bb0305","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.1111\/jcmm.16798","article-title":"Anti-inflammatory mechanisms and research progress of colchicine in atherosclerotic therapy","volume":"25","author":"Li","year":"2021","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0310","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"Libby","year":"2019","journal-title":"Atherosclerosis. Nature Reviews. Disease Primers"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0315","first-page":"17023","article-title":"NF-\u03baB signaling in inflammation. Signal transduction and targeted","volume":"2","author":"Liu","year":"2017","journal-title":"Therapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0320","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s10787-023-01199-9","article-title":"Inhibition of STAT3 phosphorylation by colchicine regulates NLRP3 activation to alleviate sepsis-induced acute lung injury","volume":"31","author":"Liu","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.947959","article-title":"Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials","volume":"9","author":"Ma","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109053_bb0330","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1471-4159.2006.04005.x","article-title":"Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: Modulation by zinc","volume":"99","author":"Mackenzie","year":"2006","journal-title":"Journal of Neurochemistry"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109053_bb0335","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1161\/01.CIR.89.5.1929","article-title":"Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells","volume":"89","author":"March","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0340","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0350","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/ph13010008","article-title":"Colchicine-binding site inhibitors from chemistry to clinic: A review","volume":"13","author":"McLoughlin","year":"2020","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"21","key":"10.1016\/j.pharmthera.2026.109053_bb0355","first-page":"1711","article-title":"Colchicine for postoperative pericardial effusion: A multicentre, double-blind, randomised controlled trial","volume":"101","author":"Meurin","year":"2015","journal-title":"Heart (British Cardiac Society)"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109053_bb0360","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.898690","article-title":"Colchicine impacts leukocyte trafficking in atherosclerosis and reduces vascular inflammation","volume":"13","author":"Meyer-Lindemann","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0370","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251326769","article-title":"Secondary stroke prevention beyond antiplatelets: The role of colchicine and GLP-1RA - an ounce of prevention is worth a pound of cure","volume":"18","author":"Mijajlovi\u0107","year":"2025","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0375","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-3659(96)01546-5","article-title":"Site-specific delivery of colchicine in rat carotid artery model of restenosis","volume":"45","author":"Mishaly","year":"1997","journal-title":"Journal of Controlled Release"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109053_bb0380","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.038687","article-title":"Cardiovascular benefit of colchicine in relation to baseline risk: A secondary analysis of the LoDoCo2 Trial","volume":"14","author":"Mohammadnia","year":"2025","journal-title":"Journal of the American Heart Association"},{"issue":"7 Pt 2","key":"10.1016\/j.pharmthera.2026.109053_bb0385","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacep.2023.01.037","article-title":"Impact of colchicine monotherapy on the risk of acute Pericarditis following atrial fibrillation ablation","volume":"9","author":"Mohanty","year":"2023","journal-title":"JACC. Clinical Electrophysiology"},{"issue":"Suppl_3","key":"10.1016\/j.pharmthera.2026.109053_bb0390","doi-asserted-by":"crossref","DOI":"10.1161\/circ.152.suppl_3.4366003","article-title":"Abstract 4366003: Anti-inflammatory effects of colchicine after myocardial infarction","volume":"152","author":"Muroke","year":"2025","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0395","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"The American Journal of Cardiology"},{"issue":"18","key":"10.1016\/j.pharmthera.2026.109053_bb0400","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/eurheartj\/ehae208","article-title":"Low-dose colchicine for atherosclerosis: Long-term safety","volume":"45","author":"Nidorf","year":"2024","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0405","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109053_bb0410","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"The New England Journal of Medicine"},{"issue":"16","key":"10.1016\/j.pharmthera.2026.109053_bb0415","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1016\/j.cell.2024.05.059","article-title":"Guidelines for minimal information on cellular senescence experimentation in vivo","volume":"187","author":"Ogrodnik","year":"2024","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109053_bb0420","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-V","article-title":"Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty","volume":"19","author":"O\u2019Keefe","year":"1992","journal-title":"Journal of the American College of Cardiology"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109053_bb0425","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIRCULATIONAHA.120.050560","article-title":"Colchicine attenuates inflammation beyond the Inflammasome in chronic coronary artery disease: A LoDoCo2 proteomic substudy","volume":"142","author":"Opstal","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0430","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.ard.2025.01.028","article-title":"EULAR\/PReS endorsed recommendations for the management of familial Mediterranean fever (FMF): 2024 update","volume":"84","author":"Ozen","year":"2025","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"45","key":"10.1016\/j.pharmthera.2026.109053_bb0435","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1093\/eurheartj\/ehae538","article-title":"Colchicine in acutely decompensated heart failure: The COLICA trial","volume":"45","author":"Pascual-Figal","year":"2024","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1016\/j.pharmthera.2026.109053_bb0440","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/oby.23632","article-title":"Immunomodulatory effects of colchicine on peripheral blood mononuclear cell subpopulations in human obesity: Data from a randomized controlled trial","volume":"31","author":"Patel","year":"2023","journal-title":"Obesity (Silver Spring, Md.)"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0445","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.V74594","article-title":"Colchicine interferes with L-selectin and leukocyte function-associated antigen-1 expression on human T lymphocytes and inhibits T cell activation","volume":"7","author":"Perico","year":"1996","journal-title":"Journal of the American Society of Nephrology"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109053_bb0450","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cvr\/cvae191","article-title":"Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction","volume":"121","author":"Psaltis","year":"2025","journal-title":"Cardiovascular Research"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2026.109053_bb0455","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijpharm.2012.10.029","article-title":"Recent advances in drug eluting stents","volume":"441","author":"Puranik","year":"2013","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0460","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/imr.12117","article-title":"The role of the cytoskeleton at the immunological synapse","volume":"256","author":"Ritter","year":"2013","journal-title":"Immunological Reviews"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0465","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.amjmed.2021.07.025","article-title":"Consensus statement regarding the efficacy and safety of long-term low-dose colchicine in gout and cardiovascular disease","volume":"135","author":"Robinson","year":"2022","journal-title":"The American Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0470","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1038\/s41467-025-61916-6","article-title":"Colchicine in patients with aortic stenosis undergoing transcatheter aortic valve replacement: A double-blind randomized trial","volume":"16","author":"Ryffel","year":"2025","journal-title":"Nature Communications"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2026.109053_bb0475","first-page":"35","article-title":"Pharmacokinetics of colchicine: A review of experimental and clinical data","volume":"30","author":"Sabouraud","year":"1992","journal-title":"Zeitschrift Fur Gastroenterologie"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109053_bb0480","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.recesp.2018.11.021","article-title":"Colchicine administered in the first episode of acute idiopathic Pericarditis: A randomized multicenter open-label study","volume":"72","author":"Sambola","year":"2019","journal-title":"Revista Espanola de Cardiologia (English Ed.)"},{"issue":"22","key":"10.1016\/j.pharmthera.2026.109053_bb0485","doi-asserted-by":"crossref","first-page":"15466","DOI":"10.1074\/jbc.M113.464461","article-title":"Control of myofibroblast differentiation by microtubule dynamics through a regulated localization of mDia2","volume":"288","author":"Sandbo","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109053_bb0490","first-page":"147","article-title":"Low dose colchicine in prevention of atrial fibrillation after coronary artery bypass graft: A double blind clinical trial","volume":"72","author":"Sarzaeem","year":"2014","journal-title":"Tehran University Medical Journal"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0495","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201469R","article-title":"Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation","volume":"37","author":"Schwarz","year":"2023","journal-title":"FASEB Journal"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0500","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s10753-015-0237-7","article-title":"Effect of colchicine on platelet-platelet and platelet-leukocyte interactions: A pilot study in healthy subjects","volume":"39","author":"Shah","year":"2016","journal-title":"Inflammation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0505","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008717","article-title":"Effects of acute colchicine administration Prior to percutaneous coronary intervention: COLCHICINE-PCI randomized Trial","volume":"13","author":"Shah","year":"2020","journal-title":"Circulation. Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0510","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.toxlet.2020.09.018","article-title":"Colchicine increases intestinal permeability, suppresses inflammatory responses, and alters gut microbiota in mice","volume":"334","author":"Shi","year":"2020","journal-title":"Toxicology Letters"},{"issue":"6","key":"10.1016\/j.pharmthera.2026.109053_bb0515","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/jat.4587","article-title":"Colchicine disrupts bile acid metabolic homeostasis by affecting the enterohepatic circulation in mice","volume":"44","author":"Shi","year":"2024","journal-title":"Journal of Applied Toxicology\u00a0: JAT"},{"issue":"10","key":"10.1016\/j.pharmthera.2026.109053_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd9100363","article-title":"Colchicine in cardiac surgery: The COCS randomized clinical Trial","volume":"9","author":"Shvartz","year":"2022","journal-title":"Journal of Cardiovascular Development and Disease"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109053_bb0525","article-title":"Colchicine for prevention of atrial fibrillation after cardiac surgery in the early postoperative period. Journal of","volume":"11","author":"Shvartz","year":"2022","journal-title":"Clinical Medicine"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109053_bb0530","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.jacep.2024.04.017","article-title":"Associations between biomarkers of myocardial injury and systemic inflammation and risk of incident ventricular arrhythmia","volume":"10","author":"Sourour","year":"2024","journal-title":"JACC. Clinical Electrophysiology"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0535","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/rheumatology\/kead625","article-title":"Colchicine: The good, the bad, the ugly and how to minimize the risks","volume":"63","author":"Stamp","year":"2024","journal-title":"Rheumatology (Oxford, England)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0540","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse events during oral colchicine use: A systematic review and meta-analysis of randomised controlled trials","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthritis Research & Therapy"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0545","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2017.09.008","article-title":"Monocyte-macrophages and T cells in atherosclerosis","volume":"47","author":"Tabas","year":"2017","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.pharmthera.2026.109053_bb0550","doi-asserted-by":"crossref","DOI":"10.1177\/0300060520939832","article-title":"Effect of low-dose ColchiciNe on the InciDence of atrial fibrillation in open heart surgery patients: END-AF low dose Trial","volume":"48","author":"Tabbalat","year":"2020","journal-title":"The Journal of International Medical Research"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0555","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ahj.2016.05.006","article-title":"Effect of ColchiciNe on the InciDence of atrial fibrillation in open heart surgery patients: END-AF Trial","volume":"178","author":"Tabbalat","year":"2016","journal-title":"American Heart Journal"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109053_bb0560","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.036701","article-title":"Neutrophil activation and adhesiveness in coronary artery disease: Results from the COLCHICINE-PCI biomarker substudy","volume":"13","author":"Talmor","year":"2024","journal-title":"Journal of the American Heart Association"},{"issue":"26","key":"10.1016\/j.pharmthera.2026.109053_bb0565","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0570","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cdtm.2015.02.002","article-title":"Tumor necrosis factor-\u03b1 and its role as a mediator in myocardial infarction: A brief review","volume":"1","author":"Tian","year":"2015","journal-title":"Chronic Diseases and Translational Medicine"},{"issue":"20","key":"10.1016\/j.pharmthera.2026.109053_bb0575","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: The Australian COPS randomized clinical Trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"issue":"2 Pt 2","key":"10.1016\/j.pharmthera.2026.109053_bb0580","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jcmg.2017.08.013","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: A CT coronary angiography study","volume":"11","author":"Vaidya","year":"2018","journal-title":"JACC. Cardiovascular Imaging"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0585","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018993","article-title":"Colchicine inhibits neutrophil extracellular trap formation in patients with acute coronary syndrome after percutaneous coronary intervention","volume":"10","author":"Vaidya","year":"2021","journal-title":"Journal of the American Heart Association"},{"issue":"34","key":"10.1016\/j.pharmthera.2026.109053_bb0590","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"European Heart Journal"},{"issue":"11","key":"10.1016\/j.pharmthera.2026.109053_bb0595","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.122.319808","article-title":"Targeting microtubules for the treatment of heart disease","volume":"130","author":"Warner","year":"2022","journal-title":"Circulation Research"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109053_bb0600","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1161\/CIRCULATIONAHA.124.071344","article-title":"Colchicine and Atherothrombosis: Another piece of the puzzle","volume":"150","author":"Weber","year":"2024","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0605","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s42255-021-00366-y","article-title":"Colchicine acts selectively in the liver to induce hepatokines that inhibit myeloid cell activation","volume":"3","author":"Weng","year":"2021","journal-title":"Nature Metabolism"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151957","article-title":"Alleviation of fibrosis and oxidative stress in pressure overload-induced cardiac remodeling and heart failure via SIRT3 activation by colchicine","volume":"770","author":"Wu","year":"2025","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0615","article-title":"Colchicine prevents atrial fibrillation promotion by inhibiting IL-1\u03b2-induced IL-6 release and atrial fibrosis in the rat sterile pericarditis model","volume":"129","author":"Wu","year":"2020","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"13","key":"10.1016\/j.pharmthera.2026.109053_bb0620","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: The COLOCT randomized clinical Trial","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113573","article-title":"Colchicine: Emerging therapeutic effects on atrial fibrillation by alleviating myocardial fibrosis in a rat model","volume":"154","author":"Yue","year":"2022","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0630","first-page":"4","article-title":"Colchicine to reduce atrial fibrillation in the postoperative period of myocardial revascularization","volume":"107","author":"Zarpelon","year":"2016","journal-title":"Arquivos Brasileiros de Cardiologia"},{"issue":"3","key":"10.1016\/j.pharmthera.2026.109053_bb0635","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41401-024-01422-5","article-title":"Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitors","volume":"46","author":"Zhai","year":"2025","journal-title":"Acta Pharmacologica Sinica"},{"issue":"4","key":"10.1016\/j.pharmthera.2026.109053_bb0640","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41401-024-01438-x","article-title":"Colchicine reduces neointima formation and VSMC phenotype transition by modulating SRF-MYOCD activation and autophagy","volume":"46","author":"Zhang","year":"2025","journal-title":"Acta Pharmacologica Sinica"},{"issue":"9","key":"10.1016\/j.pharmthera.2026.109053_bb0645","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/s41401-021-00835-w","article-title":"Therapeutic potential of colchicine in cardiovascular medicine: A pharmacological review","volume":"43","author":"Zhang","year":"2022","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/j.pharmthera.2026.109053_bb0650","doi-asserted-by":"crossref","first-page":"0089","DOI":"10.34133\/bmr.0089","article-title":"Harnessing nanotechnology for gout therapy: Colchicine-loaded nanoparticles regulate macrophage polarization and reduce inflammation","volume":"28","author":"Zhang","year":"2024","journal-title":"Biomaterials Research"},{"issue":"19","key":"10.1016\/j.pharmthera.2026.109053_bb0655","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1042\/CS20230499","article-title":"Colchicine protects against the development of experimental abdominal aortic aneurysm","volume":"137","author":"Zhao","year":"2023","journal-title":"Clinical Science (London)"},{"issue":"1","key":"10.1016\/j.pharmthera.2026.109053_bb0660","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12950-023-00366-7","article-title":"Colchicine prevents oxidative stress-induced endothelial cell senescence via blocking NF-\u03baB and MAPKs: Implications in vascular diseases","volume":"20","author":"Zhou","year":"2023","journal-title":"Journal of Inflammation"},{"issue":"5","key":"10.1016\/j.pharmthera.2026.109053_bb0665","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.RES.0000118599.25944.D5","article-title":"Transforming growth factor-beta-induced inhibition of myogenesis is mediated through Smad pathway and is modulated by microtubule dynamic stability","volume":"94","author":"Zhu","year":"2004","journal-title":"Circulation Research"},{"issue":"43","key":"10.1016\/j.pharmthera.2026.109053_bb0670","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1093\/eurheartj\/ehae546","article-title":"Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal haematopoiesis","volume":"45","author":"Zuriaga","year":"2024","journal-title":"European Heart Journal"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582600080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016372582600080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:08:36Z","timestamp":1785902916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016372582600080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":132,"alternative-id":["S016372582600080X"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109053","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Colchicine in cardiovascular medicine: Current perspectives on mechanisms and clinical therapeutics","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2026.109053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109053"}}